EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FBXO38 Regulates Nox1 Stability to Reduce Vascular Endothelial Damage Induced by Low Oscillatory Shear Stress

Wan-Li Yu iD, Li-Wen Deng iD, Huan-Huan Li iD, Chun-Kai Wang iD, Xiang-Yi Zuo iD, Zi-Chang Wang iD, Li Meng iD, Lan-Xin Wen iD, Wan-Zhi Zeng iD, Yu Zhao iD, Xue-Hu Wang iD

Cardiovascular Therapeutics · 2025

DOI: 10.1155/cdr/4506032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Therapeutics, 2025. Verfasst von Wan-Li Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: NADPH Oxidase 1, Human Umbilical Vein Endothelial Cells, Oxidative Stress, F-Box Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxidative stress and endothelial dysfunction are critical drivers of atherosclerosis, but the mechanisms regulating oxidative stress under disturbed flow conditions remain incompletely understood. The ubiquitin–proteasome system, particularly E3 ubiquitin ligases, may play a pivotal role in modulating these processes. FBXO38, an E3 ligase involved in proteasomal degradation, has been implicated in various physiological pathways, but its role in regulating oxidative stress in endothelial cells is unknown. We hypothesized that FBXO38 mitigates endothelial damage induced by low oscillatory shear stress (LOSS) by promoting the ubiquitin–proteasome–dependent degradation of Nox1, a major source of reactive oxygen species (ROS). Using an in vitro LOSS model in human umbilical vein endothelial cells (HUVECs) and an in vivo mouse partial carotid ligation model, we assessed the expression of FBXO38 and Nox1 through quantitative PCR, western blotting, immunofluorescence, and immunohistochemistry. LOSS significantly reduced FBXO38 protein expression (by ~60%, p < 0.0001 at 24 h), leading to increased Nox1 protein levels (approximately two‐fold, p < 0.001) and apoptosis. FBXO38 overexpression markedly attenuated Nox1 accumulation (~50% reduction, p < 0.05), reduced ROS production, and improved cell viability under LOSS conditions, whereas FBXO38 knockdown exacerbated these effects. Moreover, FBXO38 directly interacted with Nox1, suggesting a ubiquitin‐dependent degradation mechanism. Our results reveal that FBXO38 regulates endothelial oxidative stress by controlling Nox1 stability under disturbed shear stress conditions. Although FBXO38 emerges as a promising candidate for therapeutic targeting, further studies are necessary to validate its potential in preclinical and clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NADPH Oxidase 1Human Umbilical Vein Endothelial CellsOxidative StressF-Box ProteinsSKP Cullin F-Box Protein LigasesMechanotransduction, CellularHumansAnimalsReactive Oxygen SpeciesStress, MechanicalDisease Models, AnimalApoptosisMice, Inbred C57BLMaleProteolysisCell SurvivalCells, CulturedMiceProteasome Endopeptidase Complex

Stichwörter der Autor:innen

FBXO38Nox1apoptosisatherosclerosisloss

Substanzen

NADPH Oxidase 1Reactive Oxygen SpeciesF-Box ProteinsNOX1 protein, mouseNOX1 protein, humanSKP Cullin F-Box Protein LigasesProteasome Endopeptidase Complex

Autor:innen und Institutionen

  • Department of Vascular Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

ORCID-Profile: Wan-Li Yu, Li-Wen Deng, Huan-Huan Li, Chun-Kai Wang, Xiang-Yi Zuo, Zi-Chang Wang, Li Meng, Lan-Xin Wen, Wan-Zhi Zeng, Yu Zhao, Xue-Hu Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yu, W. L., Deng, L. W., Li, H. H., Wang, C. K., Zuo, X. Y., Wang, Z. C., Meng, L., Wen, L. X., Zeng, W. Z., Zhao, Y., & Wang, X. H. (2025). FBXO38 Regulates Nox1 Stability to Reduce Vascular Endothelial Damage Induced by Low Oscillatory Shear Stress. Cardiovascular Therapeutics. https://doi.org/10.1155/cdr/4506032

Vancouver

Yu WL, Deng LW, Li HH, Wang CK, Zuo XY, Wang ZC, et al. FBXO38 Regulates Nox1 Stability to Reduce Vascular Endothelial Damage Induced by Low Oscillatory Shear Stress. Cardiovascular Therapeutics. 2025. doi:10.1155/cdr/4506032

BibTeX
@article{Yu2025,
  author = {Yu, Wan-Li and Deng, Li-Wen and Li, Huan-Huan and Wang, Chun-Kai and Zuo, Xiang-Yi and Wang, Zi-Chang and Meng, Li and Wen, Lan-Xin and Zeng, Wan-Zhi and Zhao, Yu and Wang, Xue-Hu},
  title = {FBXO38 Regulates Nox1 Stability to Reduce Vascular Endothelial Damage Induced by Low Oscillatory Shear Stress},
  journal = {Cardiovascular Therapeutics},
  year = {2025},
  doi = {10.1155/cdr/4506032}
}
Kostenlos starten →